BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28223509)

  • 1. High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
    Tang Y; Wang Z; Li Z; Kim J; Deng Y; Li Y; Heath JR; Wei W; Lu S; Shi Q
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2544-2549. PubMed ID: 28223509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J; Sun G; Zhu H
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
    Xu C; Qian L; Yu L; Zhang X; Wang Q
    Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
    Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
    J Proteomics; 2024 Jun; 302():105201. PubMed ID: 38768894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion.
    Zhang H; Li C; Hu F; Zhang X; Shen Y; Chen Y; Li F
    Respir Res; 2020 Oct; 21(1):284. PubMed ID: 33121490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.
    Xu CH; Hao KK; Yu LK; Zhang XW
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):28-33. PubMed ID: 24720371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
    Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
    Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion.
    Yi F; Zhang X
    Medicine (Baltimore); 2019 Sep; 98(38):e17253. PubMed ID: 31567996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
    Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
    Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].
    Li R; Gao Z; Dong K; Wang H; Zhang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):175-180. PubMed ID: 30890505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species modulator 1, a novel protein, combined with carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Chen X; Zhang N; Dong J; Sun G
    Tumour Biol; 2017 May; 39(5):1010428317698378. PubMed ID: 28459208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the application of percutaneous closed pleural brushing combined with cell block technique in the diagnosis of malignant pleural effusion.
    Wang K; Hu X; Chen Y; Yi X; Han X; Zhu D; Zhu B; Luo H
    Clin Respir J; 2024 Jan; 18(1):e13705. PubMed ID: 37775991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.
    Gu Y; Zhai K; Shi HZ
    Chin Med J (Engl); 2016 Feb; 129(3):253-8. PubMed ID: 26831224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion.
    Wagner IC; Guimarães MJ; da Silva LK; de Melo FM; Muniz MT
    J Bras Pneumol; 2007; 33(2):185-91. PubMed ID: 17724538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
    Bao QL; Li J; Sun W; Jiang HG; Zhu LR; Wang Y
    Jpn J Clin Oncol; 2014 Dec; 44(12):1198-205. PubMed ID: 25425729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
    An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.
    Zhang T; Liu W; Li L; Jue Z; Xu C
    BMC Pulm Med; 2022 Aug; 22(1):307. PubMed ID: 35948914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
    Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
    Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.